Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
5.57
+0.07 (1.27%)
At close: Jun 26, 2026, 4:00 PM EDT
5.46
-0.11 (-1.94%)
After-hours: Jun 26, 2026, 7:52 PM EDT
Aligos Therapeutics Employees
Aligos Therapeutics had 82 employees as of December 31, 2025. The number of employees increased by 12 or 17.14% compared to the previous year.
Employees
82
Change (1Y)
12
Growth (1Y)
17.14%
Revenue / Employee
$57,378
Profits / Employee
-$1,101,476
Market Cap
34.47M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Senti Biosciences Holdings | 39 |
| Plus Therapeutics | 28 |
| Actinium Pharmaceuticals | 25 |
| Daré Bioscience | 24 |
| Lisata Therapeutics | 21 |
| INmune Bio | 21 |
| ABVC BioPharma | 19 |
| Barinthus Biotherapeutics | 14 |
ALGS News
- 4 weeks ago - Aligos Therapeutics initiated with a Buy at Lake Street - TheFly
- 4 weeks ago - Aligos Therapeutics presents data at EASL congress - TheFly
- 4 weeks ago - Aligos Therapeutics Presents Positive Data at the EASL Congress 2026 - GlobeNewsWire
- 5 weeks ago - Aligos Therapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 5 weeks ago - Aligos Therapeutics initiated with an Overweight at Cantor Fitzgerald - TheFly
- 6 weeks ago - Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026 - GlobeNewsWire
- 7 weeks ago - Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results - GlobeNewsWire
- 7 weeks ago - Aligos Therapeutics Earnings release: Q1 2026 - Filings